GCL Energy Technology Co-Develops China’s First Technical Standard for On-Chain Real-World Assets
SUZHOU, China, March 27, 2025 /PRNewswire/ —Â GCL Energy Technology Co., Ltd. (002015.SZ) has spearheaded the development of China’s inaugural technical... Read more.
Etsy Appoints Rafe Colburn as Chief Technology Officer
BROOKLYN, N.Y., March 27, 2025 /PRNewswire/ —Â Etsy, Inc. (NASDAQ: ETSY), which operates two-sided online marketplaces that connect millions of passionate... Read more.
Equifax Releases 2024 Security Annual Report
Fifth Annual Report Illustrates Continued Commitment to Cybersecurity Leadership and Innovation ATLANTA, March 27, 2025 /PRNewswire/ — Equifax® (NYSE: EFX)... Read more.
GlycoNex to Present Preclinical Data on GNX1021 at AACR 2025
Data highlights preclinical efficacy and safety of GNX1021, a novel glycan-targeting ADC, in gastric cancer models NEW TAIPEI CITY, Taiwan, March 27, 2025 /PRNewswire/... Read more.
Behind the Stephen Hawking Medal Scenes: STARMUS, Christopher Nolan, and Kip Thorne on Their Groundbreaking Fusion of Science and Cinema
Christopher Nolan shares his insights on the innovative blend of science and cinema that earned him the prestigious Stephen Hawking Medal for Science Communication,... Read more.
RoboSense and LionsBot Announce Strategic Partnership
SHENZHEN, China, March 27, 2025 /PRNewswire/ — RoboSense (2498.HK), a pioneering AI-driven robotics technology company, and LionsBot, a renowned robotics developer... Read more.
Latch Makes Significant Progress Towards Becoming Current with SEC Filing Obligations, Files 2023 SEC Reports, and Provides Cash Position Update
The Company continues to work diligently to file its 2024 SEC reports ST. LOUISÂ , March 27, 2025 /PRNewswire/ — Latch, Inc. (“Latch” or the “Company”),... Read more.
Actinium Pharmaceuticals Provides Business Update After Presentation at Trump Mar-A-Lago Club Announcing Novel Non-PSMA Prostate Cancer Radiotherapy ATNM-400 and Outlining Revitalized Clinical Pipeline with 2025 Corporate Objectives
– ATNM-400 is a novel, non-PSMA targeting, first-in-class Actinium-225 radiotherapy for prostate cancer with initial preclinical results to be presented at... Read more.
FlyteHealth Executive Board Chair, Dr. Cheryl Pegus, Co-Chair of newly launched Duke-Margolis Health Capital Impact Council
NEW CANAAN, Conn., March 27, 2025 /PRNewswire/ — Cheryl Pegus, MD, MPH, Executive Board Chair of FlyteHealth, is Co-Chair of the newly launched Capital Impact... Read more.
Imaflex Resumes Normal Operations Following Cybersecurity Incident
MONTRÉAL, March 27, 2025 /CNW/ – Imaflex Inc. (“Imaflex” or the “Corporation”) (TSXV: IFX) confirms to its customers and stakeholders... Read more.